Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)

Historical Holders from Q3 2021 to Q3 2025

Symbol
RGC on Nasdaq
Type / Class
Equity / Ordinary Shares, $0.00001 Par Value
Shares outstanding
494,239,409
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
633,811
Holdings value
$9,791,796
% of all portfolios
0%
Number of holders
16
Number of buys
11
Number of sells
-9
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Regencell (BVI) Ltd 88.6% +2.8% $7,461,749,817 +$7,270,529,987 437,896,116 +3,802% Yat-Gai Au 11 Jul 2025

Institutional Holders of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 633,811 $9,791,796 -$392,659 $15.45 16
2025 Q2 691,718 $11,786,875 +$10,844,555 $17.04 14
2025 Q1 8,830 $281,277 +$62,573 $31.88 5
2024 Q4 31,556 $155,887 +$66,404 $4.94 3
2024 Q3 18,114 $100,442 +$97,348 $5.55 2
2024 Q2 563 $1,892 -$3,655 $3.36 3
2024 Q1 1,651 $7,435 -$65,939 $4.5 3
2023 Q4 16,304 $171,178 +$162,803 $10.5 3
2023 Q3 662 $9,271 +$1,725 $14 4
2023 Q2 539 $11,697 -$4,939 $21.7 2
2023 Q1 736 $18,871 -$11,954 $25.88 4
2022 Q4 1,188 $32,314 -$223,077 $27.2 3
2022 Q3 8,195 $260,000 -$9,603 $31.69 5
2022 Q2 8,498 $296,000 -$146,385 $34.6 5
2022 Q1 20,245 $434,000 +$206,066 $21.42 4
2021 Q4 7,008 $230,000 -$86,000 $32.06 2
2021 Q3 13,973 $316,000 +$316,000 $22.63 3